| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Feb 27, 2024 | Sale | $0.73 | 3,405 | 2,493 | 102,306 | Feb 27, 2024, 07:54 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rothera Mark | President and CEO | Nov 30, 2023 | Buy | $0.49 | 52,094 | 25,734 | 52,094 | Dec 04, 2023, 04:54 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rothera Mark | President and CEO | Dec 01, 2023 | Buy | $0.49 | 47,906 | 23,627 | 100,000 | Dec 04, 2023, 04:54 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Nov 28, 2023 | Sale | $0.50 | 3,720 | 1,860 | 98,822 | Nov 28, 2023, 07:06 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Aug 28, 2023 | Sale | $1.45 | 3,512 | 5,092 | 95,653 | Aug 29, 2023, 06:47 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | May 25, 2023 | Sale | $1.42 | 3,635 | 5,160 | 92,277 | May 26, 2023, 07:29 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | Feb 27, 2023 | Sale | $1.68 | 2,156 | 3,625 | 48,087 | Feb 28, 2023, 06:28 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Feb 27, 2023 | Sale | $1.68 | 3,599 | 6,051 | 89,023 | Feb 28, 2023, 06:22 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Nov 28, 2022 | Sale | $2.72 | 3,532 | 9,606 | 85,733 | Nov 29, 2022, 05:33 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | Nov 28, 2022 | Sale | $2.72 | 2,116 | 5,754 | 46,116 | Nov 29, 2022, 05:25 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | Aug 26, 2022 | Sale | $4.01 | 2,190 | 8,786 | 44,105 | Aug 29, 2022, 09:18 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Aug 26, 2022 | Sale | $4.02 | 3,655 | 14,679 | 82,376 | Aug 29, 2022, 09:14 PM | |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | CEO & President | Aug 26, 2022 | Sale | $4.01 | 13,379 | 53,656 | 612,770 | Aug 29, 2022, 09:11 PM | |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | CEO & President | May 26, 2022 | Sale | $1.90 | 13,162 | 25,022 | 600,930 | May 27, 2022, 05:34 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | May 26, 2022 | Sale | $1.90 | 2,154 | 4,095 | 42,168 | May 27, 2022, 05:32 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | May 26, 2022 | Sale | $1.90 | 3,596 | 6,836 | 79,142 | May 27, 2022, 05:27 PM | |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | CEO & President | Feb 28, 2022 | Sale | $2.78 | 14,635 | 40,678 | 588,873 | Mar 01, 2022, 09:13 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | Feb 28, 2022 | Sale | $2.78 | 2,395 | 6,657 | 40,195 | Mar 01, 2022, 09:12 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Feb 28, 2022 | Sale | $2.78 | 3,998 | 11,112 | 75,849 | Mar 01, 2022, 09:10 PM | |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | CEO & President | Dec 29, 2021 | Option Exercise | $0.90 | 7,000 | 6,300 | 578,289 | Dec 30, 2021, 06:47 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | Nov 26, 2021 | Sale | $4.80 | 1,950 | 9,361 | 41,054 | Nov 29, 2021, 07:50 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | Nov 29, 2021 | Sale | $4.82 | 2,591 | 12,486 | 38,463 | Nov 29, 2021, 07:50 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Nov 26, 2021 | Sale | $4.80 | 3,254 | 15,621 | 77,283 | Nov 29, 2021, 07:48 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Nov 29, 2021 | Sale | $4.82 | 4,325 | 20,843 | 72,958 | Nov 29, 2021, 07:48 PM | |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | CEO & President | Nov 26, 2021 | Sale | $4.80 | 11,914 | 57,194 | 587,122 | Nov 29, 2021, 07:46 PM | |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | CEO & President | Nov 29, 2021 | Sale | $4.82 | 15,833 | 76,301 | 571,289 | Nov 29, 2021, 07:46 PM | |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | CEO & President | Nov 15, 2021 | Buy | $5.56 | 8,000 | 44,480 | 548,599 | Nov 15, 2021, 05:59 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Sep 28, 2021 | Option Exercise | $0.90 | 10,000 | 9,000 | 66,760 | Sep 29, 2021, 06:04 PM | |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | May 11, 2021 | Option Exercise | $1.40 | 34,750 | 48,567 | 34,750 | May 13, 2021, 05:46 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Gullotta Tina | VP, Finance | May 29, 2020 | Buy | $0.33 | 6,000 | 1,989 | 20,500 | Jun 05, 2020, 03:18 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Quinn William P. | See Remarks | May 31, 2019 | Buy | $0.65 | 6,000 | 3,877 | 121,697 | Apr 02, 2020, 03:30 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Quinn William P. | See Remarks | Nov 29, 2019 | Buy | $0.37 | 6,000 | 2,193 | 127,697 | Apr 02, 2020, 03:30 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Aisling Capital Partners IV LLC | 10% Owner | Jul 15, 2019 | Buy | $0.60 | 2,500,000 | 1,500,000 | 10,100,000 | Jul 15, 2019, 04:15 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Quinn William P. | CFO,Sr.V.P. Finance, Corp.Dev. | Dec 10, 2018 | Buy | $0.47 | 40,000 | 18,800 | 52,000 | Dec 12, 2018, 04:57 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | Nov 02, 2017 | Buy | $2.59 | 25,300 | 65,527 | 3,275,300 | Nov 06, 2017, 09:27 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | Nov 03, 2017 | Buy | $2.89 | 40,000 | 115,600 | 3,315,300 | Nov 06, 2017, 09:27 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | Nov 06, 2017 | Buy | $2.77 | 16,200 | 44,874 | 3,331,500 | Nov 06, 2017, 09:27 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Misfeldt Dayton | Director | Oct 27, 2017 | Buy | $2.00 | 400,000 | 800,000 | 1,598,260 | Oct 30, 2017, 07:30 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Parker Geoffrey M. | Director | Dec 08, 2016 | Buy | $3.87 | 3,146 | 12,159 | 13,480 | Dec 16, 2016, 05:53 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Parker Geoffrey M. | Director | Dec 09, 2016 | Buy | $3.90 | 594 | 2,318 | 14,074 | Dec 16, 2016, 05:53 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Parker Geoffrey M. | Director | Dec 08, 2016 | Buy | $3.87 | 3,146 | 12,159 | 65,151 | Dec 12, 2016, 06:43 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Parker Geoffrey M. | Director | Dec 09, 2016 | Buy | $3.90 | 594 | 2,318 | 65,745 | Dec 12, 2016, 06:43 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Parker Geoffrey M. | Director | May 26, 2016 | Buy | $0.47 | 9,500 | 4,455 | 62,005 | May 27, 2016, 05:26 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Parker Geoffrey M. | Director | May 24, 2016 | Buy | $0.46 | 30,000 | 13,881 | 30,000 | May 26, 2016, 05:04 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Parker Geoffrey M. | Director | May 25, 2016 | Buy | $0.49 | 22,505 | 10,933 | 52,505 | May 26, 2016, 05:04 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BJERKHOLT ERIC | EVP, CFO & Corp. Secretary | Feb 29, 2016 | Option Exercise | $0.75 | 34,991 | 26,243 | 100,922 | Mar 02, 2016, 07:49 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Swisher Daniel N JR | President and CEO | Feb 29, 2016 | Option Exercise | $0.75 | 55,675 | 41,756 | 266,519 | Mar 02, 2016, 07:40 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Misfeldt Dayton | Director | Dec 21, 2015 | Buy | $0.84 | 1,750,000 | 1,470,000 | 7,234,441 | Dec 21, 2015, 09:31 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Misfeldt Dayton | Director | Jul 24, 2015 | Sale | $3.64 | 3,962 | 14,422 | 105,134 | Dec 21, 2015, 09:25 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Misfeldt Dayton | Director | Jul 24, 2015 | Option Exercise | $1.91 | 2,297,570 | 4,384,716 | 5,725,104 | Dec 21, 2015, 09:25 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Swisher Daniel N JR | President and CEO | Aug 24, 2015 | Buy | $1.01 | 12,784 | 12,912 | 187,520 | Aug 26, 2015, 07:54 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Swisher Daniel N JR | President and CEO | Aug 25, 2015 | Buy | $1.01 | 12,216 | 12,338 | 199,736 | Aug 26, 2015, 07:54 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Ketchum Steven B | Director | Jul 24, 2015 | Option Exercise | $1.91 | 23,014 | 43,975 | 86,378 | Jul 28, 2015, 09:53 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BJERKHOLT ERIC | EVP, CFO & Corp. Secretary | Jul 24, 2015 | Option Exercise | $1.91 | 23,014 | 43,975 | 85,946 | Jul 28, 2015, 09:52 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Swisher Daniel N JR | President and CEO | Jul 24, 2015 | Sale | $1.60 | 71,030 | 113,408 | 174,336 | Jul 28, 2015, 09:52 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Bay City Capital Management V LLC | 10% Owner | Jul 24, 2015 | Sale | $1.91 | 2,301,532 | 4,398,425 | 5,812,491 | Jul 28, 2015, 06:32 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Craig Adam R | EVP, Development & CMO | Feb 27, 2015 | Option Exercise | $2.22 | 8,302 | 18,430 | 23,452 | Mar 02, 2015, 07:49 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BJERKHOLT ERIC | EVP, CFO & Corp. Secretary | Feb 27, 2015 | Option Exercise | $2.22 | 7,723 | 17,145 | 49,913 | Mar 02, 2015, 07:47 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Swisher Daniel N JR | President and CEO | Feb 27, 2015 | Option Exercise | $2.22 | 12,274 | 27,248 | 175,824 | Mar 02, 2015, 07:45 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Misfeldt Dayton | Director | Aug 27, 2014 | Sale | $8.16 | 100,700 | 822,014 | 4,702,560 | Aug 29, 2014, 06:31 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Misfeldt Dayton | Director | Aug 28, 2014 | Sale | $7.89 | 200,000 | 1,577,020 | 4,506,300 | Aug 29, 2014, 06:31 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Craig Adam R | EVP, Development & CMO | Aug 27, 2014 | Sale | $8.00 | 2,554 | 20,432 | 12,723 | Aug 29, 2014, 06:05 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BJERKHOLT ERIC | EVP, CFO & Corp. Secretary | Aug 27, 2014 | Option Exercise | $4.87 | 20,000 | 97,400 | 49,994 | Aug 29, 2014, 06:04 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Swisher Daniel N JR | President and CEO | Aug 27, 2014 | Option Exercise | $5.04 | 10,000 | 50,450 | 159,073 | Aug 29, 2014, 06:02 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | SANDELL SCOTT D | 10% Owner | Aug 27, 2014 | Sale | $8.17 | 108,300 | 884,811 | 4,817,733 | Aug 29, 2014, 05:42 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | SANDELL SCOTT D | 10% Owner | Aug 28, 2014 | Sale | $7.87 | 146,800 | 1,154,846 | 4,670,933 | Aug 29, 2014, 05:42 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | SANDELL SCOTT D | 10% Owner | Aug 29, 2014 | Sale | $7.51 | 11,600 | 87,070 | 4,659,333 | Aug 29, 2014, 05:42 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | KOLLURI KRISHNA KITTU | 10% Owner | Aug 28, 2014 | Sale | $7.87 | 146,800 | 1,154,846 | 4,670,933 | Aug 29, 2014, 05:41 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | KOLLURI KRISHNA KITTU | 10% Owner | Aug 29, 2014 | Sale | $7.51 | 11,600 | 87,070 | 4,659,333 | Aug 29, 2014, 05:41 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | KOLLURI KRISHNA KITTU | 10% Owner | Aug 27, 2014 | Sale | $8.17 | 108,300 | 884,811 | 4,817,733 | Aug 29, 2014, 05:41 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | KERINS PATRICK J | 10% Owner | Aug 27, 2014 | Sale | $8.17 | 108,300 | 884,811 | 4,817,733 | Aug 29, 2014, 05:41 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | KERINS PATRICK J | 10% Owner | Aug 28, 2014 | Sale | $7.87 | 146,800 | 1,154,846 | 4,670,933 | Aug 29, 2014, 05:41 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | KERINS PATRICK J | 10% Owner | Aug 29, 2014 | Sale | $7.51 | 11,600 | 87,070 | 4,659,333 | Aug 29, 2014, 05:41 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | DRANT RYAN D | 10% Owner | Aug 28, 2014 | Sale | $7.87 | 146,800 | 1,154,846 | 4,670,933 | Aug 29, 2014, 05:40 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | DRANT RYAN D | 10% Owner | Aug 29, 2014 | Sale | $7.51 | 11,600 | 87,070 | 4,659,333 | Aug 29, 2014, 05:40 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | DRANT RYAN D | 10% Owner | Aug 27, 2014 | Sale | $8.17 | 108,300 | 884,811 | 4,817,733 | Aug 29, 2014, 05:40 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BASKETT FOREST | 10% Owner | Aug 27, 2014 | Sale | $8.17 | 108,300 | 884,811 | 4,817,733 | Aug 29, 2014, 05:39 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BASKETT FOREST | 10% Owner | Aug 28, 2014 | Sale | $7.87 | 146,800 | 1,154,846 | 4,670,933 | Aug 29, 2014, 05:39 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BASKETT FOREST | 10% Owner | Aug 29, 2014 | Sale | $7.51 | 11,600 | 87,070 | 4,659,333 | Aug 29, 2014, 05:39 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BARRIS PETER J | 10% Owner | Aug 27, 2014 | Sale | $8.17 | 108,300 | 884,811 | 4,817,733 | Aug 29, 2014, 05:39 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BARRIS PETER J | 10% Owner | Aug 28, 2014 | Sale | $7.87 | 146,800 | 1,154,846 | 4,670,933 | Aug 29, 2014, 05:39 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BARRIS PETER J | 10% Owner | Aug 29, 2014 | Sale | $7.51 | 11,600 | 87,070 | 4,659,333 | Aug 29, 2014, 05:39 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BARRETT M JAMES | 10% Owner | Aug 27, 2014 | Sale | $8.17 | 108,300 | 884,811 | 4,817,733 | Aug 29, 2014, 05:38 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BARRETT M JAMES | 10% Owner | Aug 28, 2014 | Sale | $7.87 | 146,800 | 1,154,846 | 4,670,933 | Aug 29, 2014, 05:38 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BARRETT M JAMES | 10% Owner | Aug 29, 2014 | Sale | $7.51 | 11,600 | 87,070 | 4,659,333 | Aug 29, 2014, 05:38 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Growth Equity Opportunities Fund, LLC | 10% Owner | Aug 29, 2014 | Sale | $7.51 | 46,400 | 348,278 | 4,659,333 | Aug 29, 2014, 05:37 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Growth Equity Opportunities Fund, LLC | 10% Owner | Aug 27, 2014 | Sale | $8.17 | 433,200 | 3,539,244 | 4,817,733 | Aug 29, 2014, 05:37 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Growth Equity Opportunities Fund, LLC | 10% Owner | Aug 28, 2014 | Sale | $7.87 | 587,200 | 4,619,385 | 4,670,933 | Aug 29, 2014, 05:37 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BAY CITY CAPITAL LLC | 10% Owner | Aug 28, 2014 | Sale | $7.89 | 800,000 | 6,308,080 | 4,597,427 | Aug 29, 2014, 04:05 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BAY CITY CAPITAL LLC | 10% Owner | Aug 27, 2014 | Sale | $8.16 | 402,800 | 3,288,056 | 4,795,570 | Aug 29, 2014, 04:05 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Misfeldt Dayton | Director | Aug 12, 2014 | Sale | $6.77 | 37,100 | 251,230 | 4,801,377 | Aug 12, 2014, 08:49 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Misfeldt Dayton | Director | Aug 08, 2014 | Sale | $6.62 | 675,000 | 4,468,568 | 4,868,792 | Aug 12, 2014, 08:49 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Misfeldt Dayton | Director | Aug 11, 2014 | Sale | $6.90 | 31,600 | 218,103 | 4,837,783 | Aug 12, 2014, 08:49 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Bay City Capital Management V LLC | 10% Owner | Aug 08, 2014 | Sale | $6.62 | 675,000 | 4,468,568 | 4,975,709 | Aug 12, 2014, 05:54 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | BAY CITY CAPITAL LLC | 10% Owner | Aug 11, 2014 | Sale | $6.90 | 31,600 | 218,103 | 4,932,078 | Aug 12, 2014, 05:54 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | Bay City Capital Fund V Co-Investment Fund, L.P. | 10% Owner | Aug 12, 2014 | Sale | $6.77 | 37,100 | 251,230 | 4,895,081 | Aug 12, 2014, 05:54 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | SANDELL SCOTT D | 10% Owner | Aug 08, 2014 | Sale | $6.62 | 675,000 | 4,468,568 | 4,961,573 | Aug 12, 2014, 05:45 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | SANDELL SCOTT D | 10% Owner | Aug 12, 2014 | Sale | $6.76 | 35,540 | 240,190 | 4,926,033 | Aug 12, 2014, 05:45 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | KOLLURI KRISHNA KITTU | 10% Owner | Aug 08, 2014 | Sale | $6.62 | 675,000 | 4,468,568 | 4,961,573 | Aug 12, 2014, 05:45 PM | |
| SNSS | SUNESIS PHARMACEUTICALS INC | KOLLURI KRISHNA KITTU | 10% Owner | Aug 12, 2014 | Sale | $6.76 | 35,540 | 240,190 | 4,926,033 | Aug 12, 2014, 05:45 PM |
Menu